Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income margin | (150.7%) | (93.2%) | (105.9%) | (210.9%) | (263.6%) | (601.1%) | (485.5%) | 8.1% | 0.2% | (74.5%) | (119.3%) | (45.4%) | 0.6% | 5.0% | 20.8% | 28.8% | 46.0% | 36.7% | 48.2% | 43.6% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Operating Income margin is (3.0%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for Vertex Pharmaceuticals Incorporated have been 35.7% over the past three years, and 37.4% over the past five years.
As of today, Vertex Pharmaceuticals Incorporated's Operating Income margin is (3.0%), which is higher than industry median of (916.0%). It indicates that Vertex Pharmaceuticals Incorporated's Operating Income margin is Good.